Product Details for ANDA 076921
MIRTAZAPINE (MIRTAZAPINE)
7.5MG
Marketing Status: Prescription
15MG
Marketing Status: Prescription
30MG
Marketing Status: Prescription
45MG
Marketing Status: Prescription
7.5MG
Marketing Status: Prescription
Active Ingredient: MIRTAZAPINE
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076921
Product Number: 001
Approval Date: Oct 22, 2004
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
MIRTAZAPINE (MIRTAZAPINE)
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076921
Product Number: 001
Approval Date: Oct 22, 2004
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
15MG
Marketing Status: Prescription
Active Ingredient: MIRTAZAPINE
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076921
Product Number: 002
Approval Date: Oct 22, 2004
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
MIRTAZAPINE (MIRTAZAPINE)
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076921
Product Number: 002
Approval Date: Oct 22, 2004
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
30MG
Marketing Status: Prescription
Active Ingredient: MIRTAZAPINE
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076921
Product Number: 003
Approval Date: Oct 22, 2004
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
MIRTAZAPINE (MIRTAZAPINE)
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076921
Product Number: 003
Approval Date: Oct 22, 2004
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
45MG
Marketing Status: Prescription
Active Ingredient: MIRTAZAPINE
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 45MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076921
Product Number: 004
Approval Date: Oct 22, 2004
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 45MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076921
Product Number: 004
Approval Date: Oct 22, 2004
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information